Amlodipine Besylate + HydrochlorothiazideThird Party Manufacturing in India

Amlodipine Besylate + Hydrochlorothiazide works by combining a dihydropyridine calcium channel blocker and a thiazide diuretic to lower blood pressure through dual physiological pathways.

Amlodipine relaxes vascular smooth muscle by blocking the influx of calcium ions into cardiac and arterial cells. This results in significant vasodilation of peripheral and coronary arteries, which reduces peripheral vascular resistance. Simultaneously, Hydrochlorothiazide acts on the renal distal convoluted tubules to inhibit the reabsorption of sodium and chloride ions. This increase in sodium and water excretion reduces blood volume and cardiac output, leading to a long-term reduction in peripheral resistance.

Unlike single-agent therapy, this combination targets both fluid retention and blood vessel tension. The diuretic component counteracts the potential sodium retention and compensatory fluid accumulation that can occur with calcium channel blocker use. This dual mechanism results in a highly effective, synergistic antihypertensive effect. It is well-tolerated and ideal for patients with essential hypertension who require combined therapeutic modalities.

Therapeutic Uses

Amlodipine Besylate + Hydrochlorothiazide is prescribed for the treatment of:

• Essential Hypertension: Controlling moderate to severe high blood pressure in patients whose pressure cannot be controlled by a single pharmacological agent.
• Volume-Dependent Hypertension: Reducing elevated blood pressure in patients where fluid retention and sodium load contribute significantly to cardiovascular strain.
• Renal Hypertension Management: Supporting blood pressure management in patients with mild to moderate chronic kidney disease where diuretics are indicated.
• Cardiovascular Risk Reduction: Reducing the incidence of fatal and nonfatal stroke, myocardial infarction, and heart failure by stabilizing systemic vascular pressure.

Why Manufacturers Choose Amlodipine Besylate + Hydrochlorothiazide

This combination is highly popular because it addresses both volume-related and resistance-related components of high blood pressure. By offering a calcium channel blocker combined with a diuretic in a single dosage form, it provides clinicians with an excellent tool to simplify patient treatment regimens. Manufacturers choose this combination to capitalize on the vast market of patients requiring multi-drug therapy. The chemical stability of both Hydrochlorothiazide and Amlodipine Besylate allows for straightforward formulation, utilizing standard dry mixing and direct compression processes. This ensures low production costs and high-capacity efficiency in WHO-GMP certified facilities.

This makes Amlodipine Besylate + Hydrochlorothiazide one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.